Federated Hermes’s NantHealth, Inc NH Stock Holding History

Federated Hermes’s Portfolio NH Stock Details NH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-24	Closed	-$2K	–	2386
2020 Q2	$2K	Buy	+24	New	+$957	﹤0.01%	2113

Other funds holding NH

DCM

DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Federated Hermes's NH Position: Q3 2020 in Review

Federated Hermes sold out of NantHealth, Inc (NH) in Q3 2020, closing a stake of 24 shares — an estimated $2K sold.

Federated Hermes first reported a position in NH in Q2 2020 and held it in 1 quarter. The position peaked at $2K in Q2 2020. 47 funds tracked by Wall St. Rank hold NH as of Q3 2020.

Federated Hermes reported no remaining NantHealth, Inc position as of Q3 2020 after selling out during the quarter.
Federated Hermes sold 24 NantHealth, Inc shares in Q3 2020, an estimated $2K.
Federated Hermes first reported a position in NantHealth, Inc in Q2 2020 and held it in 1 quarter.
Federated Hermes's NantHealth, Inc position peaked at $2K in Q2 2020.
47 funds tracked by Wall St. Rank held NantHealth, Inc as of Q3 2020.

Based on Federated Hermes's 13F filing for Q3 2020, filed 12 Nov 2020.